The Juluca Prescription Assistance Program is a manufacturer-sponsored initiative that provides Juluca at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for virologically suppressed HIV patients switching from another regimen who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, HIV provider coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$3,700.00 | Save ~$3,630/mo |
| CVS Pharmacy | ~$3,800.00 | Save ~$3,730/mo |
| Walmart | ~$3,500.00 | Save ~$3,430/mo |
| Costco | ~$3,450.00 | Save ~$3,380/mo |
Kroger | ~$3,500.00 | Save ~$3,430/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply for and provides Juluca at no medication cost if approved. Our $69.95/month service covers full advocacy.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Juluca:
Still $3,400–$3,800 per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs folloavw guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Ingrezza assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Juluca (DTG/RPV) is a once-daily, single-tablet, two-drug HIV-1 regimen combining the INSTI dolutegravir and the NNRTI rilpivirine. It is designed as a ‘switch’ regimen for adults whose HIV is already well-controlled on a different regimen — simplifying to two drugs while maintaining viral suppression.
How Juluca Works:
Traditional HIV treatment uses three antiretroviral drugs, but two-drug maintenance regimens like Juluca allow virologically suppressed patients to reduce long-term drug exposure. Juluca combines dolutegravir, an integrase inhibitor that blocks HIV DNA integration into the host genome, and rilpivirine, a non-nucleoside reverse transcriptase inhibitor that distorts the reverse transcriptase enzyme. Together, they successfully maintain viral suppression in patients switching from an effective three-drug regimen. This approach eliminates the nucleoside reverse transcriptase inhibitor backbone, helping patients avoid long-term exposure to medications like tenofovir or abacavir.
Form and use:
Juluca is taken as a single tablet by mouth once daily and must be consumed with a meal. Specifically, the rilpivirine component requires a meal of at least 533 calories for adequate absorption, as skipping meals can lower drug levels and increase the risk of virologic failure. Patients must avoid taking calcium, iron, magnesium, or aluminum supplements within 2 hours before or 6 hours after Juluca to prevent reduced drug absorption. Additionally, proton pump inhibitors are completely contraindicated, while H2 blockers and antacids require strict timing precautions.
Generic availability:
As of 2026, there is no generic version of Juluca available in the United States. Other two-drug options include Dovato, which is used for both treatment-naïve patients and those switching regimens, as well as Cabenuva, a long-acting injectable combination given every month or every two months. For treatment-naïve adults, standard guidelines recommend first-line integrase inhibitor-based regimens such as Biktarvy, Triumeq, or Dovato.
Warnings:
Juluca carries warnings for hepatotoxicity, depression, suicidality, immune reconstitution syndrome, hypersensitivity reactions, weight gain, and neural tube defects associated with dolutegravir. Rilpivirine-specific warnings include depressive disorders and QT prolongation at high doses, and it is not recommended for patients with starting viral loads above 100,000 copies/mL. The medication also has significant drug interactions, making proton pump inhibitors contraindicated, while requiring caution with H2 blockers, antacids, rifamycins, anticonvulsants, and St. John’s wort.
Juluca costs approximately $3,400–$3,800 per 30-day supply. Through AffordMyPrescriptions, qualifying patients receive Juluca at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Juluca is for adults whose HIV is already well-controlled (virologically suppressed for at least 6 months) on another antiretroviral regimen — and who want to simplify to a two-drug regimen. Juluca is NOT for treatment-naïve patients, NOT for patients with prior treatment failure, and NOT for patients with resistance to dolutegravir or rilpivirine.
Rilpivirine absorption depends on food — specifically a meal of at least 533 calories. Taking Juluca on an empty stomach or with only a snack can reduce rilpivirine levels by 50% or more, risking virologic failure. Always take Juluca with a substantial meal.
Rilpivirine absorption depends on stomach acidity. Proton pump inhibitors (omeprazole, esomeprazole, etc.) are CONTRAINDICATED. H2 blockers (famotidine, ranitidine) must be taken at least 12 hours before or 4 hours after Juluca. Antacids must be taken at least 2 hours before or 4 hours after Juluca.
Both are two-drug dolutegravir-based single-tablet regimens. Juluca combines dolutegravir + rilpivirine; Dovato combines dolutegravir + lamivudine. Juluca is only for switch (already-suppressed) patients and requires a meal. Dovato is approved for both treatment-naïve and switch patients and is more flexible. Dovato avoids the acid-reducer interactions that Juluca has.
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. State ADAP programs may also coordinate with Medicare for HIV-treatment patients.
If denied, we explore alternatives — switching to another two-drug or three-drug regimen with its own PAP (Dovato, Biktarvy, Triumeq), state ADAP, the manufacturer’s copay program for commercially insured patients, or independent foundations. If we cannot find a path, you won’t be charged our service fee.
If you are struggling with the high cost of Juluca, our team may be able to help you access assistance programs designed to make brand HIV switch regimens affordable. Check your eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.